Newton Fund
VC Fund
San Francisco, United States
Newton Fund is a VC fund in San Francisco focused on Software and Medical. Early Stage DeepTech VC Fund
- Total investments:
- 20
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Newton Fund invests in
SoftwareMedicalHealth Care3D TechnologyBiotechnology
Stages Newton Fund invests in
SeedVenture - Series UnknownPre-SeedSeries ASeries B
Countries Newton Fund invests in
United StatesCanadaSingapore
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Lisheng Wang
|
|||
Mark Zhu
|
|||
Swati Chaturvedi
|
|||
1 more contact available
Investment Focus
Industry
- Software 9 (45%)
- Medical 5 (25%)
- Health Care 5 (25%)
- 3D Technology 3 (15%)
- Biotechnology 3 (15%)
Stage
- Seed 15 (75%)
- Venture - Series Unknown 2 (10%)
- Pre-Seed 1 (5%)
- Series A 1 (5%)
- Series B 1 (5%)
Country
- United States 17 (85%)
- Canada 2 (10%)
- Singapore 1 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Andy Reed
Director
|
Director | Total investments: 0 | Find email | |
|
Lisheng Wang
Managing Partner
|
Managing Partner | Total investments: 7 | Find email | |
|
Mark Zhu
Partner
|
Partner | Total investments: 0 | Find email | |
|
Swati Chaturvedi
General Partner
|
General Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Genomelink
|
Genomelink is a platform where people discover more with their DNA data and help businesses build, market and do research with it. The best founders in consumer genomics with real experience in the industry for many years, including M3, Inc. ($13B valued Meditech in Japan), a founding member of the Japanese version of 23andMe, and leadbioinformatician and software engineer at a joint-venture between Illumina and Sony. Raised $4M for Seed Round from Berkeley SkyDeck, SONY, and top-tier Japanese VCs. Supported by Illumina Accelerator, Carlos Bustamante Lab at Stanford University among others. | $3.5M / Seed / Jul 01, 2021 | |
Rellevate
|
Rellevate is a financial services company dedicated to empowering consumers through innovative services that allow consumers to access, move and use their money anytime, anywhere. Rellevate's products, offered primarily via employers, include a Digital Account with interest with Pay Any-Day, Bill Pay, and Send Money.Rellevate is focused onhelping employers improve employee retention, reduce turnover, boost satisfaction, and loyalty by enabling empowering consumers to take greater control over their finances via its product suite. | $1.3M / Seed / Apr 01, 2021 | |
Bambu
|
Bambu is a leading global digital wealth technology provider for financial institutions. We enable companies to make saving and investing simple and intelligent for their clients. The cloud-based platform is powered by our proprietary algorithms and machine learning tools. The company serves over 20 financial institutions globally. Founded in 2016,Bambu is headquartered in Singapore with a subsidiary in the United Kingdom and the United States and EMEA representatives. | Series B / Mar 15, 2021 | |
Mesentech
|
Mesentech is a company focused on treating diseases and medical conditions that relate to bone. They are generating a series of products, from different, but complementary approaches that will effectively address currently difficult to treat conditions.Bone can be one of the most difficult organs to access and treat with medicines. It’s hardsurface and low porosity presents challenges in adequately getting drugs to either the bone surface or to its interior. Treatment often requires administering high doses of a drug over extended periods. Not only is achievement of efficacy compromised, but also side- effects may be more prevalent and can limit treatment effectiveness.Mesentech’s lead technology is a proprietary bone targeting system that can effectively deliver small-molecule and biological drugs to the surface or to the interior of bone. Pre-clinical in-vivo models have confirmed the utility of this technology. | Seed / Feb 01, 2021 | |
WRM Software
|
WRM Software develops business productivity applications focused on improving business processes. WRM's storm manager and ops manager applications are designed to be easy-to-use and connect field and office operations seamlessly. It ensures everyone to have access to the latest information at all times. | Seed / Dec 10, 2020 | |
BRELYON
|
Brelyon is a developer of a display used to replace traditional monitors and virtual reality headgears. It was founded in 2019 and is headquartered in San Mateo, California. | $1.6M / Pre-Seed / Jul 15, 2020 | |
Avails Medical
|
Rapid digital detection of infections and treatment optimization. Accurate, rapid, digital detection of infections in any bodily fluid to indicate in real-time which drugs will be most effective at the point-of-prescription.Today the US spends $20B+ on infection detection. The market for efficient bacteria resistance detection has enormouspotential. Avails Medical is pioneering the current diagnostics market with a groundbreaking technology that targets this global health threat. Avails Medicals' cost-effective platform will transform the diagnostics market by enabling for the first time diagnostic-guided therapy at the point-of-care, reducing time-to-treatment from days to minutes. | Venture - Series Unknown / Mar 24, 2020 | |
ProteoWise
|
ProteoWise’s technology provides a unique combination of high information content, high throughput, and low cost - all while simplifying the western blot dramatically. This combination is what’s driving the genomic revolution and is needed for proteomics.ProteoWise is founded by a seasoned team of scientists from the Strittmatter Lab at YaleUniversity with a history of innovation. | $6.3M / Venture - Series Unknown / Mar 23, 2020 | |
Skycool Systems
|
At SkyCool Systems, our mission is to deliver sustainable, energy-efficient cooling solutions to customers interested in reducing energy costs and carbon footprint. We’ve pioneered radiative cooling as a technology, and shown that specially designed optical films can enable this passive approach to cooling throughout the day. These optical filmsare highly reflective to sunlight but also emit thermal radiation exceptionally well to the cold of space through our atmosphere, enabling daytime operation during the hottest hours of the day. Our core innovation is a rooftop cooling panel. We apply the radiative film to rooftop panels and integrate them with air conditioning and refrigeration systems. The panels can be used as an add-on to air conditioning and refrigeration systems and in some circumstances even replace an air condensing unit. Our technology is accelerating the transition to a cleaner and more sustainable future. | $1.7M / Seed / Jan 31, 2019 | |
ProbiusDx
|
ProbiusDx is an electronic sensing company that provides a diagnostic technology for detecting and monitoring blood concentrations. | $2.7M / Seed / Oct 26, 2018 | |
| See all 20 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
SaaS Investors
99,274 investors
Software Investors
50,021 investors
Health Care Investors
43,014 investors
Hardware Investors
40,144 investors
Biotech Investors
21,775 investors
Biotechnology Investors
19,370 investors
Medical Investors
18,848 investors
SaaS VC Funds
61,208 investors
Software VC Funds
31,919 investors
FAQ
What does Newton Fund invest in?
Newton Fund invests primarily in Software, Medical and Health Care startups, most often at Seed and Venture - Series Unknown stage. Most of the 20 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Newton Fund?
Public channels for Newton Fund include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Newton Fund?
The team at Newton Fund includes Andy Reed (Director), Lisheng Wang (Managing Partner) and Mark Zhu (Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
